Janumet | Sitagliptin & Metformin is a prescription drug used to treat Type 2 diabetes that contains a combination of biguanide and dipeptidyl peptidase-4 (DPP-4) inhibitor medications. This medication is also available in an extended-release pill prescription called “Janumet XR”.
The “sitagliptin” component of Janumet is a medication that, when combined with diet, exercise, and other medications, lowers blood sugar levels of patients who suffer from Type 2 diabetes. The drug classification of sitagliptin is that of a dipeptidyl peptidase-4 (DPP-4) inhibitor which works by increasing the amount of certain natural substances that lower blood sugar, particularly after consuming food.
The “metformin” component of Janumet is used either alone or with other medications- which can include insulin- to treat Type 2 diabetes. The drug classification of metformin is that of a biguanide. This component helps to control the amount of glucose, or sugar, in a patient’s blood, and decreases the amount of sugar produced by the liver. Metformin also increases the body’s reception to insulin.
Janumet should not be used to treat Type 1 diabetes.
The dosage of Janumet that a patient is prescribed depends on the individual’s current drug regimen. Janumet comes in two strengths, which may be adjusted in accordance to the effectiveness of the drug and the appearance of side effects:
Janumet should be taken with food, twice daily, with the maximum daily dosage not to exceed 100 mg sitagliptin/2000 mg metformin.
If you or loved one has suffered serious adverse side effects as a result of this drug, please do not hesitate to contact someone who can help you.